ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that the Company will release financial results for the first quarter ended March 31, 2016 on Thursday, May 19, 2016, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer, will host a conference call to review the financial results.

The conference call is scheduled to begin at 8:30 a.m. ET on Thursday, May 19, 2016. Participants should dial (877) 359-9508 (United States) or (224) 357-2393 (International) with confirmation code #4029515 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://edge.media-server.com/m/p/vx4zfxag, and will be archived online within one hour of its completion through May 26, 2016.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health. For more information, visit www.enzymotec.com.

Contact:

The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035 / 7012
tbui@theruthgroup.com
lroth@theruthgroup.com